might be a good short play
SQL: Hey, howdy, Colonel T-N!! (I myself did just FINE here today, & hope everybody did too who grabbed some of this.)
Totally agree! Especially with this out-of-the-blue heavy volume. :)
SQL: It appears pretty damn interesting, Boss!!
Think you found a good one for us bro!
SQL: And just now (suddenly) popped-up on BARCHART'S big list, but wasn't on there all day long:
Looks good. Slow and steady the way I like
SQL: Lots of action all over the Markets, this glorious Wall Street morning, Admiral Subs-L!!! (We have to BUST that $0.50 hurdle, behind THIS cute puppy.)
And, we just DID do that!!!!!!
Hahaha, copy that Major!
Just took a 10k share piece.
$HPCO Offering - This is the current trend. They run their stock (In this case 400%+) and then throw an offering. Isn't new, but definitely seems very common right now. With this being said, you can try and predict this and can try and play both sides (Long & Short).— Mitch Picks (@Mitch___Picks) February 10, 2023
.84 -2.32 CALL THE FBI
And then the delay hit.
great pick off.
SQL: Unless anyone had this in the Pre-Mark --- let alone yesterday --- well, this was pure SUCKERS-BAIT from the starting gate today. (Also, so-called epic 'BIG-GOVERNMENT-DEALS' simply are NOT 'trending'; if this SQL news today was about an AI-related contract with the likes of Tesla, Ebay, Amazon, Microsoft, HP, etc. --- i.e., the PRIVATE SECTORS --- then this SQL puppy would likely be SOARING in price for DAYS.)
Nice run gl SQL
$SQL: Now $1.80 !!!!!!!!!!!!!!!!!!!
BOOoooooooommmmmmmmmm.............. Gave it to you earlier when it just went
Look at it nowwwwwwwwwwwwwwwwwww !!!!!!!!!
Where my followers at......... if you like these kinda RIPPPERS, hook me up with a Sub !
I won't be able to let you know how to find these winners otherwise.
SeqLL was founded in 2013 to bring a new breed of next generation sequencing (NGS) technology, True Single Molecule Sequencing (tSMS), to the research and healthcare communities. By bringing together top-level scientists and engineers with extensive expertise in tSMS technology, SeqLL is uniquely positioned to address gaps left by standard sequencing technologies in RNA transcriptome analysis, specialty DNA analysis & beyond.
SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and novel intellectual property across multiple omics fields. The Company offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. It uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its direct RNA sequencing without conversion to complementary DNA (cDNA). The Company operates in a single business segment that includes the design, development and manufacturing of genetic analysis technologies. The Company's testing services are fully customizable to customers research needs and challenges. Its SeqLL technology is used for various application, such as life sciences research and development, liquid biopsy, clinical diagnostics and microbiome analysis.
|% Held by Insiders||37.35%|